LGCY · Legacy Education Inc. · Insider Trading

This sales price reflects a weighted average of multiple prices ranging from $11.16 to $11.445. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.

LeeAnn Rohmann is the Trustee of The LeeAnn Rollings Rohmann Trust U/A DTD 03/24/2025 and in such capacity has the right to vote and dispose of the securities held by such trust.

This sales price reflects a weighted average of multiple prices ranging from $10.3750 to $10.68. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.

LeeAnn Rohmann is the Trustee of The LeeAnn Rollings Rohmann Trust U/A DTD 03/24/2025 and in such capacity has the right to vote and dispose of the securities held by such trust.

This sales price reflects a weighted average of multiple prices ranging from $11.39 to $11.5950. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.

LeeAnn Rohmann is the Trustee of The LeeAnn Rollings Rohmann Trust U/A DTD 03/24/2025 and in such capacity has the right to vote and dispose of the securities held by such trust.

This sales price reflects a weighted average of multiple prices ranging from $10.75 to $11.20. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.

LeeAnn Rohmann is the Trustee of The LeeAnn Rollings Rohmann Trust U/A DTD 03/24/2025 and in such capacity has the right to vote and dispose of the securities held by such trust.

This sales price reflects a weighted average of multiple prices ranging from $8.5162 to $8.717. Full information regarding the number of shares purchased at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.

On October 16, 2025, the Reporting Person was granted an option ("Option") to purchase up to 29,354 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Option shall vest in equal monthly installments over a three year period with the first tranche vesting on the first month anniversary of the date of grant.

On October 16, 2025, the Reporting Person was granted an option ("Option") to purchase up to 29,354 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Option shall vest in equal monthly installments over a three year period with the first tranche vesting on the first month anniversary of the date of grant.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $9.45 to $9.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These shares are owned directly by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and indirectly by Robert deRose and Susan deRose as co-trustees of the trust.

On April 2, 2025, the Reporting Person was granted options ("Options") to purchase up to 87,209 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options shall vest in equal monthly installments over a three year period with the first tranche vesting on the date of grant.

On April 2, 2025, the Reporting Person was granted options ("Options") to purchase up to 87,209 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options shall vest in equal monthly installments over a three year period with the first tranche vesting on the date of grant.

On April 2, 2025, the Reporting Person was granted options ("Options") to purchase up to 174,418 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options shall vest in equal monthly installments over a three year period with the first tranche vesting on the date of grant.

On April 2, 2025, the Reporting Person was granted options ("Options") to purchase up to 43,604 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options shall vest in equal monthly installments over a three year period with the first tranche vesting on the date of grant.

On April 2, 2025, the Reporting Person was granted options ("Options") to purchase up to 43,604 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options shall vest in equal monthly installments over a three year period with the first tranche vesting on the date of grant.

On April 2, 2025, the Reporting Person was granted options ("Options") to purchase up to 43,604 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options shall vest in equal monthly installments over a three year period with the first tranche vesting on the date of grant.

These shares are owned directly by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and indirectly by Robert deRose and Susan deRose as co-trustees of the trust.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

These shares are owned directly by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and indirectly by Robert deRose and Susan deRose as co-trustees of the trust.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

These shares are owned directly by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and indirectly by Robert deRose and Susan deRose as co-trustees of the trust.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

These shares are owned directly by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and indirectly by Robert deRose and Susan deRose as co-trustees of the trust.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

These shares are owned directly by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and indirectly by Robert deRose and Susan deRose as co-trustees of the trust.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

These shares are owned by the Robert deRose IRA. Susan deRose disclaims beneficial ownership in the securities held by the Robert deRose IRA except to the extent of any pecuniary interest therein.

These shares are owned directly by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and indirectly by Robert deRose and Susan deRose as co-trustees of the trust.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

These shares are owned directly by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and indirectly by Robert deRose and Susan deRose as co-trustees of the trust.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

These shares are owned directly by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and indirectly by Robert deRose and Susan deRose as co-trustees of the trust.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

These shares are owned by the Robert deRose IRA. Susan deRose disclaims beneficial ownership in the securities held by the Robert deRose IRA except to the extent of any pecuniary interest therein.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

The option was granted pursuant to the Issuer's Amended and Restated 2021 Equity Incentive Plan and shall vest in monthly installments over a three year period with the first tranche vesting on October 27, 2024.

These shares are owned by the Susan deRose - IRA BDA. Robert deRose disclaims beneficial ownership in the securities held by the Susan deRose - IRA BDA except to the extent of any pecuniary interest therein.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

These shares are owned directly by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and indirectly by Robert deRose and Susan deRose as co-trustees of the trust.

Robert deRose and Susan deRose are ten percent owners of the Issuer.

These shares are owned directly by the Robert D. deRose & Susan deRose Family Trust DTD 11/18/1986 and indirectly by Robert deRose and Susan deRose as co-trustees of the trust.

Robert deRose and Susan deRose are ten percent owners of the Issuer.